GBB
AI Biomedical R&D Company
Hong Kong
August 27, 2024
The Forbes Asia 100 To Watch 2024 list has recently been announced, with Great Bay Bio successfully making the list as the only intelligent bioprocessing company featured.
https://www.forbes.com/sites/forbesasiateam/2024/08/26/forbes-asia-100-to-watch-2024/
The Forbes Asia 100 to Watch list focuses on emerging companies across the Asia-Pacific region that are gaining a strong foothold in some of the world’s hottest industries, such as space technology, biotechnology, and robotics, through rapid growth. Great Bay Bio, with its vision of "making global bioprocess development simpler and more efficient," is committed to addressing various pain points in drug development, including long development cycles, high costs, and low success rates.Perfectly aligned with the impact and contribution to the industry and region, market fit, promising business model, innovation, and a track record of sustained revenue growth in this year's Forbes list, successfully earning a spot on the ranking.
In the future, Great Bay Bio will continue to uphold its vision, dedicating itself to applying artificial intelligence platforms to drive the innovation of bioprocess technologies, making global drug discovery and CMC development faster and better, ultimately benefiting human health and value.
END
Great Bay Bio on Forbes Asia 100 to Watch 2024
Hong Kong
Aug 27, 2024
Great Bay Bio was successfully selected for Forbes Asia 100 to Watch 2024 List.
https://www.forbes.com/sites/forbesasiateam/2024/08/26/forbes-asia-100-to-watch-2024/
The Forbes Asia 100 to Watch list focuses on emerging companies across the Asia-Pacific region that are gaining a foothold in some of the world's most dynamic industries, such as space technology, biotechnology, and robotics. Great Bay Bio is committed to the vision of "Global Bioprocessing Made Simpler and More Efficient." Throughout its development, GBB has focused on addressing many pain points in drug development, such as long timelines, high costs, and low success rates. This commitment aligns perfectly with the criteria for the Forbes Aais 100 to Watch, which emphasizes industry impact, regional contributions, market alignment, promising business models, innovation, and sustained revenue growth.
In the future, Great Bay Bio will continue to commit to its vision by utilizing AI platforms to drive innovation in bioprocessing technologies. The goal is to enhance the speed and quality of global drug discovery and CMC development, ultimately benefiting human health and well-being.
END